Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the Farapoint focal catheter. The CE mark brings a new indication to the ...
ABOUT IT. PROSTATE CANCER. IT CAN BE A TOPIC MANY OF US TRY TO AVOID, ESPECIALLY WHEN IT COMES TO HOW YOU HAVE TO SCREEN FOR IT. BUT DURING THIS NATIONAL MEN’S HEALTH AWARENESS MONTH, DOCTORS HAVE A ...
LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...
Ultra-uniform nanogratings of sub-50-nm periods and near-10-nm groove widths on HOPG can be stably and efficiently fabricated by high-NA focused femtosecond laser irradiation under water immersion.
The episode also underscores the role of artificial intelligence in prostate imaging. In this episode of Pearls & Perspectives, Amy Pearlman, MD, speaks with Dan Sperling, MD, DABR, a board-certified ...
Long-term results from a phase 3 study showed that adding a focal boost to standard external beam radiotherapy (EBRT) improved 10-year biochemical disease-free survival (DFS) and reduced biochemical ...
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor–Positive, Unresectable or Metastatic Human Epidermal Growth Factor ...
Peer-reviewed findings demonstrate high disease control and quality-of-life preservation, supporting shift toward focal therapy in prostate treatment “The publication of the PRESERVE study in European ...
In a retrospective study of patients from high-volume centers undergoing salvage RARP after failure of primary prostate cancer therapy, only 1% overall experienced intraoperative complications.
Forbes contributors publish independent expert analyses and insights. Technology journalist specializing in audio, computing and Apple Macs. French luxury speaker maker Focal has announced its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results